Anti-Human GUCY2C VHH (SAA2687) from ProteoGenix; catalogue ARO-A23125; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Highly specialized and potent biotech product – Anti-Human GUCY2C VHH (SAA2687). This cutting-edge antibody is designed to target the GUCY2C protein, a key regulator of cell signaling pathways involved in various physiological processes.
The biological function of Anti-Human GUCY2C VHH (SAA2687) is to specifically bind to the GUCY2C protein and inhibit its activity. This results in a disruption of downstream signaling pathways, ultimately leading to the suppression of cell growth and proliferation. This makes it a valuable tool for researchers studying cancer, as well as other diseases where GUCY2C dysregulation is implicated.
Our Anti-Human GUCY2C VHH (SAA2687) has a wide range of applications in the field of biotechnology. It can be used as a research tool in cell culture and animal models to study the effects of GUCY2C inhibition on various cellular processes. Additionally, it can be used in diagnostic assays to detect the presence of GUCY2C in tissue samples, aiding in the diagnosis and monitoring of diseases.
The experimental use cases for Anti-Human GUCY2C VHH (SAA2687) are numerous and promising. In cancer research, it has shown potential in inhibiting tumor growth and metastasis in preclinical studies. It has also been studied for its potential in treating other diseases such as inflammatory bowel disease and obesity.
To ensure the highest quality and specificity, our Anti-Human GUCY2C VHH (SAA2687) is produced using advanced recombinant DNA technology. It is rigorously tested for purity and potency, and has been validated in various experimental models.
In summary, Anti-Human GUCY2C VHH (SAA2687) is a powerful and versatile biotech product with a specific biological function of inhibiting the GUCY2C protein. Its applications range from research to diagnostics, and its experimental use cases show promising potential in various diseases. Trust in our product to provide reliable and accurate results for your scientific endeavors. Order now and take your research to the next level.
ProteoGenix catalogue number ARO-A23125. For research use only.
Target: EC:4.6.1.2, GC-C, GUC2C, GUCY2C, Guanylyl cyclase C, Heat-stable enterotoxin receptor, Intestinal guanylate cyclase, STA receptor, STAR, hSTAR; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
